12/28/2015
`
`Lupin
`
`
`
`The Lupin Story (the—lupin-story.php)
`
`Corporate Overview
`
`Vision & Values (about-vision-valuesphp)
`
`Management (management.php)
`
`History & Milestones (history-mi|estone_php)
`
`Awards & Accolades (awards-accoladesphp)
`
`E
`C0 R
`AN IN NOVATION LED TRANSNATIONAL
`PHARMACEUTICAL COMPANY
`
`HOME (index.php) > OUR WORLD > ABOUT US > CORPORATE OVERVIEW (corporateoverviewphp)
`
`HEADQUARTERED IN MUMBAI, INDIA, LUPIN LIMITED TODAY IS AN INNOVATION LED TRAN$NA'|1ONAL PHARMA£EU'|1CAL COMPANY PRODUCING A WIDE RANGE OF QUALITY, AFFORDABLE GENERIC AND
`BRANDED FORMULATIONS AND APIS FOR THE DEVEl.OPED AND DEVELOPING MARKETS OF THE WORLD.
`
`Dr. Desh Bandhu Gupta's vision and dream to fight life threatening infectious diseases and to manufacture drugs of the highest social priority led to the formation of Lupin in the
`year 1968. His Wsion, his inimitable commitment and verve have steered Lupin to adtieving the distinction of becoming one of the fastest growing Generic phannaceutical
`companies globally. Lupin first gained recognition when it became one of the world's largest manufacturers of Tuberculosis drugs. The Company today has significant market share
`in key markets in the Cardiovascular (prils and statins), Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infeccives and NSAIDs therapy segments, not to mention global leadership
`positions in the Ann‘-TB and Cephalosporins segments.
`
`The Company's R&D endeavours have resulted in significant progress in its NCE program. The Company's foray into Advanced Drug Delivery Systems has resulted in the
`development of platform technologies that are being used to develop value-added generic pharmaceuticals. Lupin's world class manufacturing facilities, spread across India and
`Japan, have played a critical role in enabling the companies realize its global aspirations. Benchmarked to International standards, these facilities are approved by international
`regulatory agencies like US FDA, UK MHRA, Japan's MHLW, TGA Australia, WHO, and the MCC South Africa. Our Drugs and products reach over 100 countries in the world.
`
`Today, Lupin has emerged as the 6th largest and the fastest yawing Top 10 company in the US (by prescriptions), the only Asian company to achieve that distinction. The company
`is the 3rd largest Indian pharmaceutical company by sales. The Company is also the fastest growing top 10 generic pharmaceutical players in Japan and South Africa (IMS). Lupin's
`Consolidated turnover and Profit after Tax were ? 125,997 million (USD 2.06 billion) and 1 24,032 million (USD 393 million) respectively for the FY 2014—15.
`
`"Embedded in Lupin is a formula for growth which fuels creativity, performance and innovation"
`
`Dr. Desh Bandhu Gupta
`Founder and Chairman
`
`lJ«i
`
`Ian
`
`4
`
`, «
`.
`;
`
`.1
`.
`p
`
`;-
`
`3a
`
`‘
`
`y,
`
`-E
`
`r.
`.
`-
`IVI
`.‘‘,t_,;,.‘
`,2
`
`‘I.’‘.73
`
`T-
`
`-.n.
`
`'3‘
`V
`
`Z‘
`_
`
`‘
`
`Z‘
`,
`
`A
`lE.i ‘if.
`iv v rm
`
`Page 1 °f 2
`hflp://www.lupin.corn/corporate<wewiew.php
`
`SENJU EXHIBIT 2261
`LUPIN v. SENJU
`
`IPR2015—01 100
`
`1/2
`
`

`
`12/28/2015
`
`Lupin
`
`DOWNLOAD FINANCIAL HIGHLIGHTS (HTTP://WWW.LUPIN.COM/FINANCIALS.PHP)
`
`
`
` |
`
`
`
` |
`
`
`
`© LUPIN. ALL RIGHTS RESERVED
`
`http://www.lupin.com/corporate­overview.php
`
`2/2
`
`Page 2 of 2